Dr. Caterina Ramogida
Nuclear Medicinal Inorganic Chemistry
Dr. Ramogida’s biomedical research program focuses on the synthesis and development of cutting-edge radioactive drugs (radiopharmaceuticals) for diagnosing and treating cancers. The overarching goal of her research program is to use radioactive metal ions, or radiometals, as diagnostic or therapeutic tools for the improved detection and therapy of disease. As drug constituents, the flexibility of radiometals in terms of their radiological half-life, decay emission, and chemistry lends extremely well to their incorporation into radiopharmaceuticals for personalized diagnostics and therapies for cancer patients. Critically important to her research program is the design, synthesis, and characterization of novel and innovative metal ion chelators that enable promising radiometals to be attached to drug delivery molecules for imaging purposes and/or targeted treatment of cancer.
Read more: Dr. Ramogida's profile on the Department of Chemistry website.